Cutting physician reimbursement might curb potentially inappropriate use of prostate cancer therapy and lower health care costs.
University of Florida urologist Scott Gilbert, M.D., M.S., and colleagues at the University of Michigan and the University of Texas Medical Branch, evaluated national patterns of how doctors prescribed a hormone treatment called androgen deprivation therapy, before and after the Centers for Medicare and Medicaid lowered the associated…
